Established in 2024, Depth Medicare is a forward-thinking pharmaceutical company specializing in oncology. We focus on developing and globally distributing high-quality cytotoxic anticancer APIs. Driven by innovation and regulatory excellence, we strive to make effective cancer treatments more accessible and safe for patients worldwide.
Our anticancer APIs are exported to healthcare markets around the world.
We adhere to strict international pharmaceutical quality and safety standards.
We grow by staying rooted in advanced science and the evolving needs of cancer care.
Innovating new synthetic pathways and optimizing existing ones for enhanced efficiency and purity in API production.
State-of-the-art manufacturing facilities designed for high-containment and cGMP-compliant synthesis of cytotoxic compounds.
Establishing a robust supply chain to ensure timely and secure delivery of critical APIs to pharmaceutical partners worldwide.
To become a global leader in the development and manufacturing of high-quality oncology Active Pharmaceutical Ingredients (APIs), dedicated to advancing cancer care through innovation, integrity, and excellence.
We envision a future where life-saving oncology treatments are accessible, affordable, and driven by science and precision. Through sustainable practices, cutting-edge technology, and a deep commitment to quality, we aim to empower healthcare systems worldwide and make a meaningful difference in the lives of cancer patients.
At the heart of our vision is committed to:
1.Excellence in quality- Delivering APIs that, meet the highest international standards.
2.Sustainable Innovation
3.Global Accessibility- Supporting healthcare systems in both developed and emerging markets with cost effective oncology APIs.
At Depth Medicare, our mission is to deliver
high-quality, reliable and affordable Active Pharmaceutical Ingredients (APIs) that empower global healthcare solutions. We are committed to innovation, regulatory compliance and sustainable practices, ensuring the safety and efficacy.
We are committed to:
Our manufacturing infrastructure at Depth Medicare strictly adheres to Schedule-M and cGMP guidelines, ensuring high-efficiency and contamination-free production of cytotoxic anticancer APIs. With dedicated containment zones, advanced filtration systems, and stringent process controls, we maintain product purity, prevent cross-contamination, and protect both product integrity and personnel safety.
These high-quality glass assemblies are essential for controlled chemical reactions, offering exceptional visibility and chemical inertness—crucial for the safe synthesis of Active Pharmaceutical Ingredients (APIs). Designed under GMP (Good Manufacturing Practice) standards, they ensure precision, hygiene, and repeatability in lab-scale and pilot-scale processes
This stainless steel sifter ensures precise particle size uniformity and effectively removes foreign particles, which is vital for maintaining the purity of Active Pharmaceutical Ingredients (APIs). Constructed with SS 316, it offers excellent corrosion resistance and meets stringent pharmaceutical hygiene standards. The sifter plays a critical role in pre-processing, ensuring that only properly sized particles move forward in production.
The octagonal blender is designed for gentle yet highly efficient blending of dry powders and granules, ensuring homogeneity across API batches. Its unique octagonal shape promotes consistent mixing without excessive shear, preserving the physical integrity of the material.
This equipment is used for micronizing materials into ultra-fine particles, which significantly improves the bioavailability and dissolution profile of APIs. The Air Jet Mill operates through a high-velocity jet stream without mechanical grinding, ensuring a contamination-free process.
At Depth Medicare, our in-house Quality Control (QC) Laboratory ensures every batch of cytotoxic anticancer APIs meets the highest standards. From raw material inspection to final release, our integrated QC processes guarantee exceptional purity, potency, and safety.
High-Performance Liquid Chromatography provides precise quantitative and qualitative analysis of API purity and impurities, ensuring adherence to pharmacopoeial limits. The auto-injector system enhances efficiency and reproducibility.
Used for the detection and quantification of residual solvents and volatile impurities in APIs, critical for ensuring product safety and compliance with international regulations.
Confirms the identity of raw materials and final API products by analysing molecular vibrations, providing a unique spectral fingerprint for each compound.
These chambers allow for precise control across three environmental conditions (e.g., 25° C/60% RH, 30°C/65% RH, 40°C/75% RH). This is crucial for accelerated and long-term stability studies, determining API shelf-life.
Equipped for traditional chemical analysis, including various titration methods (acid-base, redox, complexometric), essential for determining API assay and excipient compatibility.
A Reverse Osmosis plant ensures a continuous supply of highly purified water for all laboratory operations, eliminating potential contaminants that could affect analytical results.
Choosing Depth Medicare means partnering with a trusted API expert committed to scientific excellence, full regulatory compliance, and advancing the fight against cancer. With specialized knowledge and advanced manufacturing, we deliver reliable solutions for the global pharmaceutical industry.
Scaling up our manufacturing capacity with advanced, high-containment zones specifically designed for sensitive cytotoxic compounds.
Actively pursuing USFDA and EUGMP approvals to unlock access to major regulated markets, reinforcing our commitment to global quality standards.
Establishing a state-of-the-art research and development facility to drive innovation in oncology API synthesis and discover novel compounds.
Forging strategic joint ventures and oncology formulation partnerships to expand our reach and integrate vertically within the pharmaceutical value chain.
Have questions about our APIs or partnership opportunities? Reach out to our team to learn how we can support your oncology pipeline.
Depth Medicare is a GMP certified pharmaceutical company specializing in cytotoxic oncology APIs. With a focus on quality, innovation, and global compliance, we support life saving cancer therapies through reliable API manufacturing and trusted partnerships.
Plot no.207&209, GIDC-ll, Ghanghli Road, Sihor-364240 Bhavnagar ,Gujarat
